Expression of an epidermal antigen used to study tissue induction in the early Xenopus laevis embryo

A monoclonal antibody (Epi 1) has been produced that recognizes an antigen expressed in epidermal cells of Xenopus laevis embryos. The Epi 1 antigen appears in embryonic epidermis at the end of gastrulation and is not expressed in nonepidermal structures derived from ectoderm (for example, neural tube or cement gland). The capacity to express the Epi 1 antigen is restricted to cells of the animal hemisphere prior to the midblastula stage of development (stage 8), and tissue interactions during gastrulation inhibit the expression of the Epi 1 antigen in neural ectoderm. This epidermal antigen will be a valuable marker for studies of ectodermal commitment.     

Inhibition of lymphocyte blastogenesis by whey

Bovine whey samples were evaluated by use of lymphocyte-transformation tests to determine their effect on lymphocyte blastogenesis. Whey samples from mammary glands with clinical mastitis strongly inhibited DNA synthesis and blastogenesis in lymphocytes stimulated with mitogens or dividing because of bovine leukemia virus infection. Whey samples from apparently healthy glands either did not inhibit lymphocyte DNA synthesis or inhibited it to a lesser degree than did whey from mastitic glands. Degree of inhibition was dose-dependent. The molecules causing inhibition were noncytotoxic and underwent minimal binding to the lymphocytes. Inhibitory molecules were susceptible to various proteolytic and glycolytic enzymes, indicating a glycoprotein-like structure. Whey inhibited incorporation of thymidine if it was in the cell cultures during the early stages of stimulation. Incubation of lymphocytes in whey that inhibited thymidine incorporation did not affect DNA synthesis in subsequent culturing of the same cells without whey. Degree of inhibition was affected by the method of whey preparation.     

Influence of selection for milk yield on endogenous hormones and metabolites in Holstein heifers and cows

Plasma concentrations of prolactin (PRL), growth hormone (GH), insulin, glucagon, glucose, urea and free fatty acids (FFA) were measured in Holstein calves, yearlings, bred heifers and primiparous cows, either sired by bulls with high predicted differences (PD) for milk (selection group) or by bulls from an unselected random bred control population (control group; n = 6). Serial blood samples were collected before and after feeding for an 8-h period from 0900 to 1700 h. All animals were fed a complete feed at 1100 h and administered insulin (.6 IU/100 kg body weight) at 1400 h. Mean plasma PRL was greater in control animals after feeding and insulin administration, while GH was greater overall in selection cattle. Insulin remained elevated longer in selection animals after exogenous administration, and plasma glucagon was increased in the control group. While plasma glucose and urea were unaffected by genetic group, plasma FFA were elevated in selection group calves and primiparous cows compared with the control group. All hormones and metabolites differed among the pre- and post-feeding and insulin administration periods and also with age. Mean PRL and GH increased after feeding, while glucagon decreased after exogenous insulin. Plasma FFA declined after feeding, while urea and glucose were similar before and after feeding. Mean PRL increased and glucagon decreased with advancing age and plasma GH and insulin showed inverse relationships at different ages. Plasma FFA changes closely followed GH changes with age, while plasma glucose more closely followed insulin changes with age. Results indicate that all hormones measured and FFA responded to genetic selection for milk, and increases in GH are uniformly associated with increased genetic potential for milk yield.     

Histological evaluation of ovine mammary tissue xenografted into cyclosporine-treated mice

Histological and pathological alterations of ovine mammary parenchyma xenografted into cyclosporine-treated mice were studied. Forty-two mature, virgin female mice were assigned randomly to one of four treatments: 1) control, 2) control + estrogen/progesterone, 3) cyclosporine, and 4) cyclosporine + estrogen/progesterone. All mice received two subcutaneous mammary tissue explants taken from an estrogen and progesterone-primed ewe. After 3, 7, 14, 21, and 35 d, mice were killed and tissue was removed for an evaluation of epithelial morphology on a scale from 1 (poor) to 5 (excellent). Leukocyte type and number were determined in subepithelial stroma. The mean epithelial score for tissue collected on d 7 and d 21 were higher (P less than .05) for cyclosporine treatments (3.0) than for controls (1.6). Scores also were greater (P less than .01) when cyclosporine was combined with estrogen and progesterone than when cyclosporine was the sole treatment (3.8 vs 2.3). Epithelial scores for tissue recovered from mice given cyclosporine and steroids up to 35 d were not different from those of explants fixed at zero time. However, scores were lower (P less than .05) for three of five time periods for explants recovered from mice given cyclosporine alone. Lymphocyte number was higher (P less than .07) in controls (66) than in mice given cyclosporine and steroids (13 per field). The correlation between lymphocyte number and epithelial score was -.55. These results indicate that ovine mammary tissue xenografted into mice treated with cyclosporine can maintain a normal histological structure for an extended period of time.     

Increased degradation of insulin-like growth factor-I in serum from feed-deprived steers

Severe feed restriction decreases serum insulin-like growth factor I (IGF-I) concentration in animals, and this decrease is thought to be due to reduced IGF-I production in the liver. The objective of this study was to determine whether feed deprivation also increases degradation of serum IGF-I and serum levels of IGF binding protein 3 (IGFBP-3) and acid-labile subunit (ALS), which inhibit IGF-I degradation and increase IGF-I retention in the blood by forming a ternary complex with IGF-I, in cattle. Five steers had free access to pasture, and another five were deprived of feed for 60 h. Serum concentration of IGF-I and liver abundance of IGF-I mRNA at the end of the 60-h period were 50% and 80% lower, respectively, in feed-deprived steers than in fed steers. Less ¹²⁵I-labeled IGF-I remained intact after a 45-h incubation in sera of feed-deprived steers than in sera of fed steers, suggesting that serum IGF-I is more quickly degraded in feed-deprived animals. Serum levels of IGFBP-3 and ALS were decreased by 40% and 30%, respectively, in feed-deprived steers compared with fed steers. These decreases were associated with more than 50% reductions in IGFBP-3 and ALS mRNA in the liver, the major source of serum IGFBP-3 and ALS. Taken together, these results suggest that feed deprivation reduces serum concentration of IGF-I in cattle not only by decreasing IGF-I gene expression in the liver, but also by increasing IGF-I degradation and reducing IGF-I retention in the blood through decreasing IGFBP-3 and ALS production in the liver.     

Chloramphenicol 1. Hazards of use and the current regulatory environment

Chloramphenicol is a broad-spectrum antibiotic which has enjoyed extensive use in both medical and veterinary practice. Shortly after its introduction in the late 1940s, the use of chloramphenicol was associated with the induction of an idiosyncratic form of aplastic anaemia in man. This rare and unpredictable adverse effect has since been associated not only with systemic use but with topical applications, as well as occupational exposure. Recognition of the small risk of a potentially fatal adverse reaction, together with the risk of selection of chloramphenicol-resistant pathogens, has led to restrictions on the veterinary uses of chloramphenicol. In Australia at present, the use of chloramphenicol is only permitted in small animals. Its use is specifically prohibited in food-producing animals, including horses.     

Diethylstilboestrol—historical background and current regulatory status

Diethylstilboestrol is a non-steroidal orally active oestrogen that in the past has been widely used in a variety of conditions in both medical and veterinary fields. In recognition of potential systemic availability to man of DES in the tissues of treated food-producing animals, together with an understanding of the potential teratogenic and carcinogenic toxicity of DES in man, the veterinary use of DES has been restricted to oral use in small animals only. Use of DES is prohibited in all food-producing animals.